IN

Indrani Narra

Active Director Director DIN 02252938
DIN 02252938 First appointment Oct 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 1 historical roles
Total affiliations 10 Since Oct 2003
Shareholding value •••• Premium profile

About Indrani Narra

Data last updated:

Indrani Narra is a Director at Lepranal Pharmaceuticals Private Limited (since 2003), Managing Director at Ik Media And Broadcasting India Private Limited (since 2025) and Additional Director at Breathe Life Hospitals And Healthcare Private Limited (since 2023), and holds 6 more current directorships. The companies operate in Pharma, Healthcare and Information Technology. The largest current company by reported revenue is Lepranal Pharmaceuticals Private Limited at ₹36 Lakh (FY 2025). Earlier, Indrani Narra was a Director at Indivara Media And Broadcasting India Private Limited (from 2019).

DIN 02252938
Primary Designation Director
Industry Pharma
First Appointment 27 Oct 2003
Oldest Company Age 43 yrs
Largest company Lepranal Pharmaceuticals Private Limited · ₹36 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Oct 20031983₹36 Lakh (FY 2025)Active
Managing Director23 Oct 20252025Active
Additional Director01 Apr 20232021Active
Ink Systems India Private Limited U72900TG2017PTC115726
Director07 Mar 20172017Active
Ikin Mega Projects Private Limited U45201TG2017PTC114369
Director02 Feb 20172017Active
Kin Pharma Private Limited U74999TG2017PTC114107
Director17 Jan 20172017Active
Ink Pharma Private Limited U74999TG2017PTC114069
Director16 Jan 20172017Active
Director03 Jan 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Mar 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lepranal Pharmaceuticals Private Limited
Ikin Mega Projects Private Limited
Ink Soft Private Limited
Ink Systems India Private Limited
Premium access

Shareholding and investment profile for Indrani Narra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indrani Narra

Indrani Narra currently holds 9 directorships: Lepranal Pharmaceuticals Private Limited (Director, since 27 Oct 2003, revenue ₹36 Lakh (FY 2025)); Ik Media And Broadcasting India Private Limited (Managing Director, since 23 Oct 2025); Breathe Life Hospitals And Healthcare Private Limited (Additional Director, since 01 Apr 2023); Ink Systems India Private Limited (Director, since 07 Mar 2017); Ikin Mega Projects Private Limited (Director, since 02 Feb 2017); and 4 more.

Indrani Narra was first appointed on 27 Oct 2003 as Director at Lepranal Pharmaceuticals Private Limited. The most recent appointment on record is 23 Oct 2025 at Ik Media And Broadcasting India Private Limited.

Indrani Narra held 1 earlier board appointment: Indivara Media And Broadcasting India Private Limited (Director, from 01 Mar 2019).

The current boards of Indrani Narra's companies include Krishna Rao Narra (Lepranal Pharmaceuticals Private Limited), Vijaya Kollu (Ik Media And Broadcasting India Private Limited), Kiran Reddy Sannapareddy (Breathe Life Hospitals And Healthcare Private Limited), Sowjanya Sannapureddy (Breathe Life Hospitals And Healthcare Private Limited), Krishna Rao Narra (Ink Systems India Private Limited), Ramana Kalvakolanu (Ink Systems India Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available